This exploratory analysis of a randomized clinical trial investigates the effect of KIT and PDGFRA mutations on recurrence-free survival in a population of patients with gastrointestinal stromal tumors treated with surgery and adjuvant imatinib.
http://ift.tt/2nbtP1O
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου